Specifically, the Group focuses on the development and application of structural MS techniques to interrogate the structure, dynamics, and function of challenging membrane proteins. Membrane proteins constitute the main targets of most known drugs. However, structural knowledge of these important biomolecules is limited by the lack of tools that can accurately monitor their conformational states and structural motions in physiologically relevant conditions. Research in the Group will address such challenges by developing the emerging HDX-MS technology to interrogate the dynamic signatures of membrane proteins and their complexes.
Establishing a leading research unit at BSRC Fleming to advance biomolecular mass spectrometry and structural biology for biomedical innovation.
MASSTRUCT is funded by the “Widening Participation & Spreading Excellence” component of Horizon Europe Programme (ERA Chairs: HORIZON-WIDERA-2023-TALENTS-01), under Grant Agreement No. 101183630.
Masstruct © Copyright 2025. Design & Development by DotSense